On Wednesday, tech giant Google announced, via a blog post, that it has launched a new tool called ‘Gmailify’, to give non-Gmail users the ability to access the best features of Google’s popular Gmail email service.
The new ‘Gmailify’ features enables users to link their existing email accounts on Microsoft Outlook, Hotmail, or Yahoo Mail, to avail the advantages of the ‘perks’ offered by the Google email service, without changing their current email address.
Some of the most noteworthy Gmail ‘perks’ which can now be availed by non-Gmail users via the Gmailify feature include advanced spam detection and blocking mechanism, a tabbed inbox for better organization of emails, and Google Now cards, among several others.
Announcing the new Gmailify feature, Google said in the blog post that initially the feature works only works with Microsoft Outlook and Yahoo Mail. However, the company has efforts underway to expand the availability of the Gmailify feature to more email providers in the future.
Google also said that the rollout of the Gmailify feature will “bring the best of Gmail to more people,” and added: “Many of you would like more of Gmail's powerful features, like spam protection and inbox organization, on these accounts -- but don't want to go through the hassle of changing your email address.”
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).